WO1996012730A1 - Separation d'acides amines et de peptides a partir d'hydrolysats proteiques - Google Patents
Separation d'acides amines et de peptides a partir d'hydrolysats proteiques Download PDFInfo
- Publication number
- WO1996012730A1 WO1996012730A1 PCT/NZ1995/000107 NZ9500107W WO9612730A1 WO 1996012730 A1 WO1996012730 A1 WO 1996012730A1 NZ 9500107 W NZ9500107 W NZ 9500107W WO 9612730 A1 WO9612730 A1 WO 9612730A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- resin
- anion exchange
- amino acids
- peptides
- protein
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 65
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 51
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 49
- 108010009736 Protein Hydrolysates Proteins 0.000 title claims abstract description 12
- 239000003531 protein hydrolysate Substances 0.000 title claims abstract description 11
- 238000000926 separation method Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 61
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 57
- 125000003118 aryl group Chemical group 0.000 claims abstract description 20
- 230000007935 neutral effect Effects 0.000 claims abstract description 20
- 230000008929 regeneration Effects 0.000 claims abstract description 19
- 238000011069 regeneration method Methods 0.000 claims abstract description 19
- 238000005349 anion exchange Methods 0.000 claims abstract description 17
- 229920005989 resin Polymers 0.000 claims description 124
- 239000011347 resin Substances 0.000 claims description 124
- 239000000413 hydrolysate Substances 0.000 claims description 38
- 235000018102 proteins Nutrition 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 108010076119 Caseins Proteins 0.000 claims description 21
- 239000005018 casein Substances 0.000 claims description 21
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 21
- 235000021240 caseins Nutrition 0.000 claims description 21
- 239000005862 Whey Substances 0.000 claims description 19
- 108010046377 Whey Proteins Proteins 0.000 claims description 19
- 102000007544 Whey Proteins Human genes 0.000 claims description 19
- 239000003957 anion exchange resin Substances 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 238000005342 ion exchange Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 7
- 230000001172 regenerating effect Effects 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940001941 soy protein Drugs 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 55
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 32
- 239000003463 adsorbent Substances 0.000 description 32
- 229960004799 tryptophan Drugs 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 150000001450 anions Chemical class 0.000 description 27
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 26
- 239000002585 base Substances 0.000 description 22
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 20
- 229920001429 chelating resin Polymers 0.000 description 20
- 230000008569 process Effects 0.000 description 20
- 229910019142 PO4 Inorganic materials 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 16
- 239000010452 phosphate Substances 0.000 description 16
- 239000012610 weak anion exchange resin Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 239000003456 ion exchange resin Substances 0.000 description 12
- 229920003303 ion-exchange polymer Polymers 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- 235000019658 bitter taste Nutrition 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 238000003795 desorption Methods 0.000 description 7
- KCUNTYMNJVXYKZ-JTQLQIEISA-N methyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate Chemical compound C1=CC=C2C(C[C@H](N)C(=O)OC)=CNC2=C1 KCUNTYMNJVXYKZ-JTQLQIEISA-N 0.000 description 7
- 239000008057 potassium phosphate buffer Substances 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229920003002 synthetic resin Polymers 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000424 optical density measurement Methods 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 description 3
- 239000012609 strong anion exchange resin Substances 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 2
- RFCVXVPWSPOMFJ-STQMWFEESA-N Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-STQMWFEESA-N 0.000 description 2
- 108010001441 Phosphopeptides Proteins 0.000 description 2
- LYMVXFSTACVOLP-ZFWWWQNUSA-N Trp-Leu Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 LYMVXFSTACVOLP-ZFWWWQNUSA-N 0.000 description 2
- XCTHZFGSVQBHBW-IUCAKERBSA-N Val-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])C(C)C XCTHZFGSVQBHBW-IUCAKERBSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229940023913 cation exchange resins Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 108010073101 phenylalanylleucine Proteins 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010080629 tryptophan-leucine Proteins 0.000 description 2
- 108010036320 valylleucine Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000006167 equilibration buffer Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000012500 ion exchange media Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000004702 methyl esters Chemical group 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000012492 regenerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
- A23L5/273—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption using adsorption or absorption agents, resins, synthetic polymers, or ion exchangers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/04—Processes using organic exchangers
- B01J41/07—Processes using organic exchangers in the weakly basic form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to a method of separating amino acids and peptides from protein hydroiysates.
- the invention relates to the removal of hydrophobic amino acids
- Hydroiysates are produced by enzymatic cleavage of proteins to manufacture products with
- hydroiysates of casein, whey and soy proteins are produced commercially.
- Such hydroiysates are desirable products for use with both humans and animals.
- such hydroiysates are useful when the subject has digestive problems such as an incapability to break down whole proteins in the digestive tract.
- the action of the enzymes during the hydrolysis process causes the release of hydrophobic peptides which are perceived as bitter.
- the maximum level of incorporation of such hydroiysates is limited by the bitter taste. Therefore for oral administration, it is desirable that the amount of these compounds in the product be lowered to achieve an acceptable taste.
- bitter hydrophobic peptides can be lowered in concentration or removed by the use of adsorbents such as activated carbon, or synthetic resins such as XAD4 and XAD7 (Rohm and Haas) or HP20 and HP21 (Mitsubishi Kasei Corporation) where the base matrix is composed of a polymer with hydrophobic properties such as styrene-divinyl benzene, acrylate or methacrylate.
- adsorbents such as activated carbon, or synthetic resins such as XAD4 and XAD7 (Rohm and Haas) or HP20 and HP21 (Mitsubishi Kasei Corporation) where the base matrix is composed of a polymer with hydrophobic properties such as styrene-divinyl benzene, acrylate or methacrylate.
- Japanese Patent 59-159792 to Meiji Confectionary KK entitled "Manufacture of Casein Phosphopeptide” is directed to a new method of manufacture of Casein Phosphopeptide via the hydrolysis of casein by trypsin.
- the bitter taste, which is caused by the presence of peptides in the trypsin hydrolysate is removed by the use of activated carbon or cation exchange resins.
- Anion exchange resins are disclosed as being unsuitable for use in the removal of the bitter peptides from the mixture.
- the patent discloses the reclaiming of the column through the suitable treatment with acid/alkali or by calcination regeneration.
- the invention in a first aspect comprises a method for separating hydrophobic amino acids and peptides containing aromatic groups from protein hydroiysates using anion exchange media.
- the invention further comprises a method for separating hydrophobic amino acids and peptides containing aromatic groups from a mixture of protein hydroiysates comprising:
- the hydrophobic peptides separated from the protein hydroiysates contain one or more amino acid unit(s) with an aromatic group.
- the anion exchange resin is a hydrophobic base matrix with a weak base ion- exchange functionality.
- the weak base ion-exchange functionality has a pK a or pK a 's in the pH range of substantially 2.0 to substantially 9.0, more preferably between 2.0 and 6.0.
- the ion-exchange resin is regenerated by removing the bound amino acids and peptides from the ion exchange resin using a combination of low pH and high temperature.
- the pH at which the resin is used to bind the amino acids and peptides is greater than the pH required to completely ionise the weak base functionality.
- this pH is between substantially 4.0 to substantially 9.0 and more preferably between 6.5 and 8.0.
- the pH used to remove the bound compounds from the ion exchange resin is sufficiently low to create an ionised form of the weak base functionality.
- this is between substantially 1.5 and substantially 6.0 and more preferably between substantially 1.5 and substantially 4.0.
- the temperature used in the regeneration of the ion exchange resin is between substantially 45°C and 100°C, more preferably between substantially 50°C and substantially 100°C, and most preferably between substantially 60°C and substantially 80°C.
- the protein hydroiysates are derived from animal products or plants.
- the protein hydroiysates are hydroiysates of casein, whey, or soy protein.
- the invention further comprises a process for the separation of hydrophobic amino acids and proteins containing aromatic groups from protein hydroiysates using a hydrophobic anion exchange resin with a weak base functionality comprising the steps of:
- the invention is directed to the separation of hydrophobic amino acids and peptides containing aromatic groups from protein hydrolysate mixtures using anion exchange media.
- ion exchange resins generally have not been thought to be suitable for use in large scale separation processes for this purpose as it was thought that sufficient selectivity of binding the compounds of concern to the surface of the resins did not exist for practical industrial production purposes.
- anion exchangers with a weak base functionality and hydrophobic base matrix at a substantially neutral pH will bind hydrophobic amino acids and peptides containing aromatic groups to the surface of the resin and thus remove them from the hydrolysate mix (an adsorption stage).
- the types of amino acids and peptides that can be selectively removed are in general terms the hydrophobic amino acids and peptides containing aromatic groups. Such compounds include phenylalanine, tyrosine, tryptophan and peptides thereof as well as others as are well known in the art. When used in the dairy industry, this separation method can be advantageously used to de-bitter hydroiysates of casein or whey for example. The bitter taste caused by combinations of amino acids having hydrophobic end groups can be removed if
- hydrophobic base matrices (1) hydrophobic base matrices
- the ion-exchangers useful in the process of the invention are generally comprised of a weak base group such as a primary, secondary or tertiary amine with a pK, or pK s in the range of pH 2.0 to pH 9.0 that are attached to a particulate matrix with hydrophobic character such
- Anion exchange resins are subtantially neutral in charge when the pH of the equilibrating solution is above the pK a of the base ligand.
- the preferred anion exchange resins are those with weak base ion-exchange groups that are substantially neutral at neutral pH. The more the equilibrating pH is above the pK a of the weak anion exchange resin, the lower the density of charged groups on the surface of the resin.
- the preferred resins for this invention are substantially neutral, enhancing the interaction between the hydrophobic amino acids and peptides and the resin.
- the pH range can be as wide as pH 4.0 to pH 9.0 depending on requirements as will be known in the art. More neutral pH's between substantially 6.5 and 8.0 are however preferred.
- Suitable resins will have all the above properties.
- Exemplary commercial resins include: Relite A329 from Sybron/Relite, which is the best of the surveyed resins. Others, such as Purolite A 103, Purolite A 100 (Purolite International), Amberlite IRA93SP (Rohm and Haas), Dowex MWA1 (Dow Chemical Company) are also suitable, but are not as effective as Relite A329 because their binding capacities are less.
- Other suitable resins as will be known in the art may also be used.
- the process of the invention includes the ability to regenerate the anion exchange resin. This relies on the ability to alter the surface charge of the resin, and thus the hydrophobicity and strength of adsorption of the hydrophobic substances onto the resin. This is achieved by lowering the pH of the solution to substantially lower than the pK avail of the ion-exchange groups on the resin. This induces charged groups on the resin surface thus releasing the bound substances.
- the resin used in the process of the present invention can therefore be regenerated by lowering the pH surrounding the resin, preferably at high temperature, causing the amino acids and peptides to unbind from the resin surface thus regenerating the resin for further use (a regeneration step).
- the pH can be lowered by the use of any suitable acid or buffer (eg HC1,
- the pH is lowered to between substantially 1.5 to 6.0 although a pH between 1.5 and 4.0 is considered most suitable.
- a temperature of between 45°C and 100°C enhances the regeneration step. This may be achieved by the use of hot water or the like as will again be known in the art. Temperatures between 50°C and 100°C are preferred with temperatures between 60°C and 80°C being considered most suitable.
- the hydrophobic ion-exchangers with weak base functionality have been substituted for conventional non-ion exchange adsorbents with the amino acids binding to the ion- exchanger in the uncharged form (ie at the substantially neutral pH). A shift to lower pH to
- the process of the present invention can be carried out with resins that have an established history and acceptability of use in food processes. Moreover, the resins can be readily regenerated for reuse without the application of strong caustic, acids or toxic solvents, again giving better acceptability in food applications for example.
- the present invention requires only sufficient acid to alter the charge on the anion exchange resin to result in release of the bound substances. It does not require excessive amounts of acids that may be recommended to clean ion exchange media on an empirical basis. In conventional ion exchange processes anion exchange resins are regenerated by the use of strong alkali. While the method of the present invention operates preferentially at low temperatures for the adsorption stage and at high temperatures for elution (ie the regeneration step), the process will be carried out with resins that have an established history and acceptability of use in food processes. Moreover, the resins can be readily regenerated for reuse without the application of strong caustic, acids or toxic solvents, again giving better acceptability in food applications for example.
- the present invention requires only sufficient acid to
- ion exchange resins do not easily foul with large molecules because the charge on the resin covers most of the surface and only smaller molecules, such as the smaller peptides, will be able to bind in the spaces between the charges on the resin surface;
- the ion exchangers can be operated in the neutral range and not in the hydroxide form eliminating base catalysed amino acid degradation which allows the recovery of the bound amino acids for potential later use.
- the process is carried out by first washing the ion-exchanger according to manufacturer's recommendation and then washing in the presence of a salt (e.g. NaCl or the like).
- a salt e.g. NaCl or the like.
- the ion-exchanger is then washed with buffer or water to achieve the desired pH for adsorption of amino acids and peptides, which is above the pK a of the weak base ligands
- the adsorption step be carried out at low temperature to promote adsorption of the hydrophobic amino acids, and that the regeneration be carried out at high temperature to facilitate elution of the hydrophobic amino acids.
- the resins can be washed with water and re-used without further equilibration if the "irocess
- hydrolysate has significant buffering capacity to result in an equilibrium at a substantially neutral pH. If this is not the case, sufficient alkali must be added to achieve this.
- model bitter substances commonly associated with hydroiysates were used in the following examples.
- Such substances include L-Tryptophan, an aromatic amino acid with hydrophobic properties, and its derivative L-Tryptophan methyl ester.
- the carboxylic acid group is derivatised to the non-charged methyl ester form, eliminating any charge effects of this group.
- Synthetic polymeric resins based on polystyrene and acrylic are more hydrophobic than resins based on agarose, for example.
- L-Tryptophan (L-Trp) Binding of L-Tryptophan (L-Trp) to a number of synthetic weak and strong anion exchange resins, a synthetic hydrophobic adsorbent, and a hydrophilic weak anion exchange resin was tested as follows. Solutions of L-Trp (0.5% w/v) were prepared in 0.01M potassium phosphate, 0.5M NaCl buffer, pH 7.4, and mixed in batch mode with samples of each of the resins listed in Table 1 (10 mL/g wet resin) at 30°C for 16 hours.
- Resin Matrix type Resin type L-Tryptophan bound - mg/g wet resin
- the hydrophobic adsorbent and the eight synthetic weak anion exchange resins bound the greatest amounts of L-Trp with varying efficiencies.
- the two synthetic strong anion exchange resins and the hydrophilic agarose resin bound very minimal amounts of L-Trp.
- Relite A329 was washed with 0.5M NaCl for 1 hour, rinsed with distilled water, and then equilibrated into 0.01M potassium phosphate buffer, pH 7.4. Diaion HP20 was equilibrated into 0.01 M potassium phosphate buffer, pH 7.4. L-Tryptophan (L-Trp, 0.5% w/v in 0.01M potassium phosphate buffer, pH 7.4) was mixed with each resin in batch mode (10 mL L- Trp/g wet resin) at 30°C for 2 hours, and then filtered off. The resins were washed with the equilibration buffer. Samples of both resins, bound with L-Trp, were suspended in water and then titrated to the following pH values using either 0.1M HC1 or 0.1 M NaOH as appropriate:
- Relite A329 and Diaion HP20 were prepared as outlined in Example 2, and L-Trp was again bound to both resins under the conditions described.
- Half of the resin samples were titrated to pH 4 using 0.1M HC1 and the other half remained at pH 7.4.
- Resin samples at both pH conditions were mixed at 20°C, 50°C and 70°C for 1 hour.
- L-Trp released from the resins was removed by filtration and measured by OD at 270 nm.
- a sample of each resin was suspended in 0.1M NaCl, instead of water, and was mixed at pH 7.4 and 20°C. Again the released L-Trp was measured by OD at 270 nm.
- Table 3 The results are shown in Table 3.
- L-Trp from the weak anion exchange resin was achieved with a combination of low pH (pH 4.0) and high temperature (70°C). Release of L-Trp from the adsorbent was significantly improved with increasing temperature, but unaffected by a drop in pH. As in Example 2, a shift in pH to ionise the weak anionic resin, provided a mechanism for release of the hydrophobic amino acid.
- Relite A329 was treated in the following manner: washed with hot water (70°C), equilibrated in 0.5M NaOH, washed with cold distilled water (20°C), re-equilibrated into 0.5M NaCl and then given a final rinse with distilled water (20°C).
- L-Tryptophan methyl ester L-Tryptophan methyl ester (L-TrpME, 0.5%w/v in 0.01M potassium phosphate buffer, pH 6.5) were added to 1 gram samples of washed resin and mixed for 1 hour at 20°C. The resin samples were filtered to remove unbound L-TrpME and washed with 0.0 IM potassium phosphate buffer, pH 6.5. A number of eluents were added to the resins and shaken for 1 hour at either 20°C or 80°C (see Table 4). L-TrpME released from the resin samples was removed by filtration and measured by OD at 270 nm against a standard curve of L-TrpME. The pHs of the final soltuions were measured. The results are shown in Table 4 and Figure 3.
- the resins used in this example were washed in 0.5M NaOH, rinsed with distilled water, and equilibrated into 0.5M NaCl. Prior to use, they were given a final rinse in distilled water. 0.5%w/v solutions of L-TrpME in 0.01M potassium phosphate buffer, pH 6.5, were added to resin samples (lOmL/g wet resin) and mixed for 1 hour at 20°C. The resin samples were filtered to remove unbound L-TrpME, and were washed with buffer.
- Desorption of the amino acid from the resins was performed by mixing the resin samples with either 0.05M HCl or 0.01 M potassium phosphate buffer, pH 6.5. for 1 hour at either 20°C or
- the Macronet resins have either no surface charge (MN 200 and MN250) or only low densities of charged groups (MN100 and MN150, 0.4-0.6 mmoles/g dry resin), their regeneration properties at low pH were similar to the adsorbent resin, XAD 16. With Relite A329, 100% desorption of L-TrpME was achieved at low pH because of the much greater charge density of this resin (1.2 mmoles/g dry resin). Optimum desorption of the amino acid was achieved with low pH, high temperature and high density of charges on the resin.
- the aim of this experiment was to investigate whether the bitter components in the casein and whey hydroiysates, ie the hydrophobic amino acids, di and tri peptides, could be as effectively removed from the hydroiysates using a synthetic weak anion exchange resin, as compared to
- Relite Casein 1.0 10 0.543 1.990 Acceptable A329 hydrolysate Relite Casein 1.0 50 0.714 2.088 Bitter
- the weak anion exchange resin (Relite A329) was as effective as the 2 adsorbents at reducing the bitter taste of whey and casein hydroiysates.
- the capacity of all three resins to remove bitter components was exceeded at a ratio of 5g hydrolysate to lg resin.
- Relite A 329 was equally as effective as Diaion HP20, but slightly less effective than Diaion HP21, at removing aromatic amino acids from the hydroiysates.
- amino acids tryptophan, phenylalanine and tyrosine contain aromatic rings, whilst valine, leucine and glycine contain aliphatic straight chains. All of these amino acids, and peptides containing these, except glycine, have hydrophobic properties and hence contribute to the bitter taste of hydroiysates.
- Relite A329 was washed with 0.5M NaOH and then rinsed with distilled water. The pH of
- the resin was titrated to pH 7.0 using 0.5M HCl, and then rinsed again with distilled water. Amberlite XAD 16 was used as supplied.
- Table 8 describes the various adsorbents and resins that have been used in the previous Examples.
- the table details the name of the manufacturer, the resin type, the trade name of the resin, and the matrix type.
- Purolite A100 Purolite Weak anion Styrene DVB International exchanger
- Purolite A 103 Purolite Weak anion Styrene DVB International exchanger
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38180/95A AU3818095A (en) | 1994-10-20 | 1995-10-20 | Separation of amino acids and peptides from protein hydrolysates |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ26474094 | 1994-10-20 | ||
NZ264740 | 1994-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996012730A1 true WO1996012730A1 (fr) | 1996-05-02 |
Family
ID=19924979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NZ1995/000107 WO1996012730A1 (fr) | 1994-10-20 | 1995-10-20 | Separation d'acides amines et de peptides a partir d'hydrolysats proteiques |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3818095A (fr) |
WO (1) | WO1996012730A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047310A1 (fr) * | 2003-11-07 | 2005-05-26 | Novexin Limited | Procedes de separation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4075195A (en) * | 1976-08-31 | 1978-02-21 | Kraft, Inc. | Debittered protein product and method for manufacture |
AU7615081A (en) * | 1980-10-09 | 1982-04-22 | Hoechst A.G. | Alpha amylase inhibitor |
AU5510490A (en) * | 1984-12-21 | 1990-10-25 | Biogen, Inc. | Purification, production and use of tumor necrosis factors |
JPH04190797A (ja) * | 1990-11-27 | 1992-07-09 | Fuji Oil Co Ltd | ペプチド混合物の製造法及びペプチド混合物を含有する飲料 |
JPH04341193A (ja) * | 1991-05-14 | 1992-11-27 | Kanebo Ltd | ペプチド又はその塩の取得方法 |
-
1995
- 1995-10-20 AU AU38180/95A patent/AU3818095A/en not_active Abandoned
- 1995-10-20 WO PCT/NZ1995/000107 patent/WO1996012730A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4075195A (en) * | 1976-08-31 | 1978-02-21 | Kraft, Inc. | Debittered protein product and method for manufacture |
AU7615081A (en) * | 1980-10-09 | 1982-04-22 | Hoechst A.G. | Alpha amylase inhibitor |
AU5510490A (en) * | 1984-12-21 | 1990-10-25 | Biogen, Inc. | Purification, production and use of tumor necrosis factors |
JPH04190797A (ja) * | 1990-11-27 | 1992-07-09 | Fuji Oil Co Ltd | ペプチド混合物の製造法及びペプチド混合物を含有する飲料 |
JPH04341193A (ja) * | 1991-05-14 | 1992-11-27 | Kanebo Ltd | ペプチド又はその塩の取得方法 |
Non-Patent Citations (4)
Title |
---|
CHEMICAL ABSTRACTS, Volume 114, No. 25, issued 24 June 1991, OHTA, HIDEAKI et al., "Amino-nitrogen Content and Free Amino Acids of Pineapple Juice Deacidified by Means of Ion Exhange Resins", page 655, Abstract No. 246141j; & KINKI CHUGOKU NOGYO KENKYU, 1990, (80), 59-63, (JAPAN). * |
DERWENT WPAT ONLINE ABSTRACT, Accession No. 92-280115; & JP,A,04 190 797, (FUJI OIL CO LTD), 9 July 1992. * |
DERWENT WPAT ONLINE ABSTRACT, Accession No. 93-13419; & JP,A,04 341 193, (KANEBO LTD), 27 November 1992. * |
JOURNAL OF CHROMATOGRAPHY, Vol. 237, issued 1982, DIZDAROGLU M. et al., "Separation of Peptides by High - Performance Liquid Chromatography on a Weak Anion - Exchange Bonded Phase", pages 417-428. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047310A1 (fr) * | 2003-11-07 | 2005-05-26 | Novexin Limited | Procedes de separation |
Also Published As
Publication number | Publication date |
---|---|
AU3818095A (en) | 1996-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU661090B2 (en) | Process for the production of biologically active substances from milk and related raw materials | |
JP4286325B2 (ja) | Gmpを含む乳原料の処理法 | |
JP5967665B2 (ja) | Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法 | |
CA2143280C (fr) | Methode pour separer le phytate des proteines vegetales grace a l'echange ionique | |
JP2012520666A (ja) | 乳清成分の単離と精製 | |
US4834994A (en) | Method for removing β-lactoglobulin from bovine milk whey | |
JP2974434B2 (ja) | 分泌性コンポネント含有組成物 | |
CN101367863A (zh) | 获得植物蛋白质和/或肽的方法、根据所述方法生产的蛋白质和/或肽、及其用途 | |
WO1996012730A1 (fr) | Separation d'acides amines et de peptides a partir d'hydrolysats proteiques | |
AU686568B2 (en) | Method of isolating biomolecules by ion exchange | |
AU777698B2 (en) | Process for separation of whey proteins using a novel anion exchanger | |
JP2002532383A (ja) | 生物学的液体からペプチドを製造する方法及びその方法で得られるペプチド | |
JPH03262495A (ja) | 高純度遊離型シアル酸の製造方法 | |
EP0398544B1 (fr) | Purification d'hydrolysats de protéines | |
JP2003335795A (ja) | 水溶性タンパク質溶液の精製法 | |
JPH06276955A (ja) | 大豆蛋白質の脱臭方法 | |
Schutyser et al. | The isolation of proteins from whey with a new strongly acidic silica-based ion exchanger | |
JPS59159792A (ja) | カゼインホスホペプチドの製造法 | |
JPH1057100A (ja) | 混床式の糖液精製装置 | |
JPH03244392A (ja) | ホスホペプタイドの分離濃縮法 | |
JPH0778080B2 (ja) | 乳からラクトフエリンを分離、精製する方法 | |
MXPA99010313A (en) | Method for treating a lactic raw material containing gmp | |
JP2006254794A (ja) | 糖液精製システムにおけるフェノール系吸着樹脂の再生方法および糖液精製装置 | |
PL51391B1 (fr) | ||
JPH02107156A (ja) | 乳ミネラル濃縮物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 294948 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 817796 Date of ref document: 19970418 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |